Drugs / DuraPrep
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | DURAPREP | — | 2006-09-29 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03393819 | Oct 2014 → Jan 2016 | osteoarthritis, hip, prosthesis-related infectious disease | Lakehead University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01290978 Comparator | Feb → Mar 2010 | — | Solventum US LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DuraPrep | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03393819 ↗ |
| Known as | 3M DuraPrep Surgical Solution | “3M™ DuraPrep™ Surgical Solution” NCT01290978 ↗ |
| Route | Topical | “The application sites (subjects' backs) will be prepped with DuraPrep according to manufacturer's instruction.” NCT01290978 ↗ |